FDA grants accelerated approval for Avmapki™ + Fakzynja™ in KRAS-mutant LGSOC. The decision was supported by Phase 1 FRAME trial led by Prof. Udai Banerji and RAMP 201 led by Prof. Susana Banerjee. Our thanks to all the patients & their families. #VerastemOncology, #ICR, #RoyalMarsden
2
0
0
0